Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review
<p>Abstract</p> <p>Background</p> <p>Rofecoxib is a cyclo-oxygenase 2 selective inhibitor. This systematic review of rofecoxib in acute pain examined studies in adults of analgesic efficacy over six hours, the amount and quality of the evidence on extended duration of a...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2002-06-01
|
| Series: | BMC Anesthesiology |
| Online Access: | http://www.biomedcentral.com/1471-2253/2/4 |